Literature DB >> 30867731

NDNF inhibits the migration and invasion of human renal cancer cells through epithelial-mesenchymal transition.

Lingling Xia1,2, Shi Li1,2, Yang Liu1,2,3, Yuqian Huang1,2, Beibei Ni1,2, Lili Wan1,2,3, Hongbing Mei1,2, Xianxin Li4, Zhiming Cai1,2, Zesong Li1,2.   

Abstract

Neuron-derived neurotrophic factor (NDNF) is a glycosylated, disulfide-bonded secretory protein that contains a fibronectin type III domain. NDNF has been identified as a neurotrophic factor; however, its role in carcinogenesis has not yet been identified. To investigate the expression and role of NDNF in carcinogenesis, the expression of NDNF in human Renal cell carcinoma (RCC) cell lines and tissues was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot analysis. Cell proliferation was investigated using CCK-8 and colony formation assays, and the cell invasion and immigration capacity was evaluated using the transwell assay. The results demonstrated that NDNF expression was downregulated in RCC cell lines and RCC tissues. Restoring NDNF expression significantly inhibited the proliferation, migration and invasion of RCC cells. The study also demonstrated that the inhibitory effect of NDNF on invasive ability was mediated by suppressing the epithelial-mesenchymal transition (EMT) in RCC cells. NDNF may therefore be considered an important regulator of EMT in RCC progression and may represent a novel promising target for antimetastatic therapy.

Entities:  

Keywords:  EMT; NDNF; RCC; invasion; migration

Year:  2019        PMID: 30867731      PMCID: PMC6396104          DOI: 10.3892/ol.2019.9937

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  8 in total

1.  Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.

Authors:  Ya Zhang; Xuefeng Wu; Yan Kai; Chia-Han Lee; Fengdong Cheng; Yixuan Li; Yongbao Zhuang; Javid Ghaemmaghami; Kun-Han Chuang; Zhuo Liu; Yunxiao Meng; Meghana Keswani; Nancy R Gough; Xiaojun Wu; Wenge Zhu; Alexandros Tzatsos; Weiqun Peng; Edward Seto; Eduardo M Sotomayor; Xiaoyan Zheng
Journal:  JCI Insight       Date:  2019-12-19

2.  The NDNF-like factor Nord is a Hedgehog-induced extracellular BMP modulator that regulates Drosophila wing patterning and growth.

Authors:  Shu Yang; Xuefeng Wu; Euphrosyne I Daoutidou; Ya Zhang; MaryJane Shimell; Kun-Han Chuang; Aidan J Peterson; Michael B O'Connor; Xiaoyan Zheng
Journal:  Elife       Date:  2022-01-17       Impact factor: 8.140

3.  PAPP-A functions as a tumor suppressor and is downregulated in renal cell carcinoma.

Authors:  Yanxin Lu; Shi Li; Tongyu Wang; Ximian Liao; Longyi Mao; Zesong Li
Journal:  FEBS Open Bio       Date:  2021-05-02       Impact factor: 2.693

4.  [Differential mRNA expression in C57BL/6 mice with bleomycin-induced pulmonary fibrosis and its association with LncRNA co-expression network].

Authors:  Xuefei Yu; Li Li; Linxin Zheng; Weifeng Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

5.  Silencing circZFR inhibits the proliferation, migration and invasion of human renal carcinoma cells by regulating miR-206.

Authors:  Mi Wang; Yisheng Gao; Jie Liu
Journal:  Onco Targets Ther       Date:  2019-09-13       Impact factor: 4.147

6.  Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a.

Authors:  Yang Liu; Weiwei Cui; Ruihong Zhang; Sujuan Zhi; Lanlan Liu; Xuyue Liu; Xiaoning Feng; Yanru Chen; Xiaoli Zhang; Jing Hao
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

7.  Gene-Based Network Analysis Reveals Prognostic Biomarkers Implicated in Diabetic Tubulointerstitial Injury.

Authors:  Sumin Wu; Wei Li; Binhuan Chen; Xuefeng Pei; Yangjian Cao; Yuting Wei; Ye Zhu
Journal:  Dis Markers       Date:  2022-08-31       Impact factor: 3.464

8.  Long non‑coding RNA HCG18 facilitates the progression of laryngeal and hypopharyngeal squamous cell carcinoma by upregulating FGFR1 via miR‑133b.

Authors:  Hongbin Peng; Pingjiang Ge
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.